当前位置:首页 - 行情中心 - 盟科药业-U(688373) - 财务分析 - 利润表

盟科药业-U

(688373)

  

流通市值:42.72亿  总市值:53.30亿
流通股本:5.25亿   总股本:6.56亿

利润表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、营业总收入66,969,753.0933,216,965.04130,272,762.0197,562,309.83
  营业收入66,969,753.0933,216,965.04130,272,762.0197,562,309.83
二、营业总成本209,906,680.3496,412,359.38581,598,318.57394,736,146.75
  营业成本10,189,199.845,138,953.4122,405,200.9417,337,542.92
  税金及附加339,228.53286,212.87407,657.1189,872.24
  销售费用48,488,509.122,406,451.74110,491,483.3581,584,801.56
  管理费用29,846,478.512,922,537.366,295,410.2943,878,114.42
  研发费用116,413,285.7953,852,131.73368,564,368.34244,246,074.92
  财务费用4,629,978.581,806,072.3313,434,198.547,599,740.69
  其中:利息费用6,323,076.823,149,649.1811,152,052.449,083,372.02
  其中:利息收入1,902,760.85849,401.232,369,037.681,876,598.02
三、其他经营收益
  加:公允价值变动收益4,261,022.111,465,382.5717,081,843.8811,834,083.76
  资产处置收益4,427.6349,427.6327,456.31-
  信用减值损失(新)-305,646.54-109,123.09-1,637,220.51-221,984.55
  其他收益905,168.65158,286.611,364,746.04440,637.84
四、营业利润-138,071,955.4-61,631,420.62-434,488,730.84-285,121,099.87
  加:营业外收入500--2,546.7
  减:营业外支出487,264.631,055.0722,886.1316,286.13
五、利润总额-138,558,720.03-61,632,475.69-434,511,616.97-285,134,839.3
  减:所得税费用115,772.52-6,209,600.126,161,306.69
六、净利润-138,674,492.55-61,632,475.69-440,721,217.09-291,296,145.99
(一)按经营持续性分类
  持续经营净利润-138,674,492.55-61,632,475.69-440,721,217.09-291,296,145.99
(二)按所有权归属分类
  归属于母公司股东的净利润-138,674,492.55-61,632,475.69-440,721,217.09-291,296,145.99
  扣除非经常损益后的净利润-143,358,346.31-63,304,517.43-459,172,377.19-303,584,607.02
七、每股收益
  (一)基本每股收益-0.21-0.09-0.67-0.44
  (二)稀释每股收益-0.21-0.09-0.67-0.44
八、其他综合收益-2,175,638.72-816,039.596,175,113.781,623,228.55
  归属于母公司股东的其他综合收益-2,175,638.72-816,039.596,175,113.781,623,228.55
九、综合收益总额-140,850,131.27-62,448,515.28-434,546,103.31-289,672,917.44
  归属于母公司股东的综合收益总额-140,850,131.27-62,448,515.28-434,546,103.31-289,672,917.44
公告日期2025-08-202025-04-242025-03-182024-10-25
审计意见(境内)标准无保留意见
TOP↑